The WACC of Keros Therapeutics Inc (KROS) is 7.1%.
Range | Selected | |
Cost of equity | 7.90% - 13.20% | 10.55% |
Tax rate | 26.20% - 27.00% | 26.60% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 5.8% - 8.4% | 7.1% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.88 | 1.49 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 7.90% | 13.20% |
Tax rate | 26.20% | 27.00% |
Debt/Equity ratio | 1 | 1 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 5.8% | 8.4% |
Selected WACC | 7.1% | |